The director of Public Health for Spain, Pilar Aparicio, said yesterday, Sunday, that there is no basic difference in the effectiveness of the Pfizer and Moderna vaccines so there is no need to establish any priorities when deciding which one to administer.
In a statement issued by Spanish Health ministers it’s been agreed to use both vaccines indiscriminately and it will depend primarily on logistical issues, which as the Moderna vaccine was developed in Spain, should help speed up the process.
Aparicio said that the EMA was about to evaluate the Moderna Vaccine on Wednesday, January 6th, and from then on it will be widely available. It is easier to store than the Pfizer vaccine at temperatures of -25 to -15ºC with a 28 day gap between the two doses, and an efficacy rate of 94.1%.
From then on, with more information, Public health will decide on a course of action to effectively use both vaccines for citizens of Spain, adding that the vaccine has been tested in clinical trials on more than 30.000 people and no shortcuts had been taken in consideration of its safety.
